Zymeworks EVP files Form 3 with no holdings
Zymeworks Inc. executive vice president and general counsel Paul R. Schneider filed an initial Form 3 indicating he currently has no securities beneficially owned in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zymeworks Inc. executive vice president and general counsel Paul R. Schneider filed an initial Form 3 indicating he currently has no securities beneficially owned in the company. The filing lists holding entries showing zero shares and no derivative securities, so it reflects a baseline ownership position of none.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | No securities are beneficially owned | -- | -- | -- |
| Holding | No securities are beneficially owned | -- | -- | -- |
Footnotes (1)
- F1. Not applicable.
Key Figures
Key Terms
beneficially owned financial
Form 3 regulatory
reporting person regulatory
derivative securities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Paul R. Schneider’s Form 3 for ZYME show about his holdings?
Who is the reporting person on this Zymeworks Inc. (ZYME) Form 3?
Are there any buy or sell transactions reported in this ZYME Form 3?
Does the Zymeworks Inc. Form 3 disclose any derivative securities for Paul R. Schneider?
AI-generated analysis. How Rhea-AI works. Not financial advice.